Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-022904

EVP & Chief R & QA Officer sold 22,400 shares at $40.07 ($897,568)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Clark Mitchall G. EVP & Chief R & QA Officer 2018-03-29 Sale −22,400 $40.07 $897,568 133,671 D
Open-market sales · 22,400 sh · avg $40.07 · $897,568
Loading xslF345X03/doc4.xml…